Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitors.
暂无分享,去创建一个
Tyler T. Risom | E. Laird | S. Gloor | J. Rudolph | Steve Wenglowsky | David Moreno | Linjing Ren | W. Voegtli | H. L. Sturgis | S. Wenglowsky